AKT2 knockdown by RNA interference suppresses cell proliferation and induces apoptosis even increases chemosensitivity in lung adenocarcinoma [40], malignant gliomas [41,42], pancreatic cancer [43] and ovarian cancer [44]. This evidence concerns the gene AKT2 and ovarian carcinoma.